CD8A and cancer: Despite the low efficacy of TMB in these cancer types, significant correlations have been reported between TMB-H and response to ICIs in several other cancer types such as melanoma, lung, and bladder cancers where CD8 T-cell levels positively correlated with neoantigen load ([16, 18]).